9068 Results

Congress Abstract

early prediction of parotid gland function based on ADC during radiotherapy for NPC: a phase Ⅱ study

Authors:

Mei Feng1,2, He Wang1, Jun Yin1, Jing Ren1, Jinyi Lang1

1Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Radiation Oncology Key Laboratory of Sichuan Province, Chengdu, China; 2The Third People's Hospital of Sichuan Province, Department of Oncology, The Third People's Hospital of Sichuan Province, Chengdu, China

Show Affiliations

Congress Abstract

Urethral sparing increases the therapeutic ratio in dose escalated hypofractionated radiotherapy

Authors:

Simon Spohn1, Ilias Sachpazidis2, Rolf Wiehle2, Benedikt Thomann2, August Sigle3, Peter Bronsert4, Juri Ruf5, Matthias Benndorf6, Nils Nicolay1, Tanja Sprave1, Anca Grosu1, Dimos Baltas2, Constantinos Zamboglou1

1University Medical Centre, Department of Radiation Oncology, Freiburg, Germany; 2University Medical Centre, Division of Medical Physics, Department of Radiation Oncology, Freiburg, Germany; 3University Medical Centre, Department of Urology, Freiburg, Germany; 4University Medical Centre, Institute for Surgical Pathology, Freiburg, Germany; 5University Medical Centre, Department of Nuclear Medicine, Freiburg, Germany; 6University Medical Centre, Department of Radiology, Freiburg, Germany

Show Affiliations

Journal Article

Erratum to : ‘Recommendations of the EVA GEC ESTRO Working Group: prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education’[Radiother. Oncol. 59 (2001) 339-360]

Authors: Richard Pötter, Erik Van Limbergen, Wim Dries, Youri Popowski, Veronique Coen, Claudia Fellner, Dietmar Georg, Christian Kirisits, Peter Levendag, Hans Marijnissen, Ugo Marsiglia, Jean-Jaques Mazeron, Boris Pokrajac, Pierre Scalliet, Vittorio Tamburini

Congress Abstract

Surgical Tolerability after Chemoradiotherapy. Preliminary Data of phase III OPERA in rectal cancer

Authors:

Jean-Pierre GERARD1, Nicolas Barbet2, Brice Thamphya3, Amandeep Dhadda4, Nicolas Magné5, Laurent Mineur6, Mélanie DEBERNE7, Thomas Zilli8, Arthur Sun Myint9

1Centre Antoine Lacassagne, Radiothérapie, Nice, France; 2Centre Bayard, Radiothérapie, Villeurbanne, France; 3Centre Antoine Lacassagne, Biostatistique, Nice, France; 4Yorkshire hospitals, clinical oncology, HULL, United Kingdom; 5Institut de cancérologie Loire, radiothérapie, Saint Priest en Jarest, France; 6Institut Sainte Catherine, radiothérapie, Avignon, France; 7CHU Lyon Sud, radiothérapie, Pierre Bénite, France; 8Hopital Universitaire Genève, radiothérapie, Genève, Switzerland; 9Cancer center Clatterbridge - Liverpool, radiothérapie, Liverpool, United Kingdom

Show Affiliations

Congress Abstract

Evaluation of a markerless SGRT-only workflow for breast cancer patients

Authors:

Tim-Oliver Sauer1, Daniel Popp1, Oliver J. Ott1, Christoph Bert1

1Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Radiation Oncology, Erlangen, Germany

Show Affiliations

Journal Article

Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates

Authors: Javier Vijande, Åsa Carlsson Tedgren, Facundo Ballester, Dimos Baltas, Panagiotis Papagiannis, Mark J. Rivard, Frank-André Siebert, Larry De Werd, Jose Perez-Calatayud

Congress Abstract

Metastasis-free survival after salvage radiotherapy in post-operative prostate cancer patients in the PSMA PET/CT era – a bi-institutional, retrospective analysis

Authors:

Nina-Sophie Schmidt-Hegemann1, Anca L. Grosu 2, Juri Ruf3, Christian Gratzke 4, Sonja Adebahr2, Christian Stief5, Peter Bartenstein6, Claus Belka7, Minglun Li 7, Christian Trapp1, Paul Rogowski1, Constantinos Zamboglou 2

1LMU University Hospital, Radiation Oncology, Munich , Germany; 2University Hospital Freiburg , Radiation Oncology, Freiburg , Germany; 3University Hospital Freiburg , Nuclear Medicine , Freiburg , Germany; 4University Hospital Freiburg , Urology , Freiburg , Germany; 5LMU University Hospital, Urology , Munich, Germany; 6LMU University Hospital, Nuclear Medicine, Munich, Germany; 7LMU University Hospital, Radiation Oncology, Munich, Germany

Show Affiliations
*:*